Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
International Stem Cell Corp logo

International Stem Cell Corp

ISCO
United States flag
OTCQX

Sector: Healthcare   

Industry: Biotechnology

0.45
 
USD
  
0.00
  
(0.00%)
Optionable: No  Market Cap: 4 M  90-day average vol: 2,991

Previous close: 0.449  Open: 0.36  Bid:   Ask:
52 week range    
0.30   
   0.80
Peers   
CMRX / 
IBIO / 
CYDY / 
Last updated: Thursday 14th April 2022

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics
Financials

ISCO Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends2 M
AcquisitionExpense-1 M-2 M
Amortization of intangibles-117000.0-129000.091000.091000.081000.0
Basic EPS from continuing operations-0.04
Basic EPS total-0.34-1.46-0.33-0.04
Basic weighted shares outstanding572906.0820586.01 M3 M4 M6 M8 M8 M8 M8 M
Cost of sales-1 M-2 M-2 M-2 M-2 M-4 M4 M10 M9 M8 M
Depreciation-420000.0-403000.0-396000.0162000.0171000.0137000.0
Depreciation unreconciled-209000.0-187000.0-191000.0-156000.0-162000.0-171000.0
DepreciationAndAmortization-420000.0-403000.0-396000.0-209000.0-187000.0-191000.0-156000.0162000.0171000.0137000.0
Diluted EPS total-19.5-13.5-9.0-0.34-1.46-0.33-0.57-0.36-0.11-0.04
Diluted normalized net income/share-0.57-0.36-0.11-0.04
Diluted weighted shares outstanding504256.0776222.01 M3 M4 M6 M8 M8 M8 M8 M
GainOnSaleOfPPE1000000.041000.0
GainOnSaleOfSecurity38000.0
GeneralAndAdministrativeExpense7 M6 M6 M5 M5 M5 M7 M4 M4 M3 M
Gross operating profit3 M5 M12 M5 M5 M7 M6 M7 M7 M8 M
ImpairmentOfCapitalAssets-330000.0-1 M-607000.0-1.0-65000.0-250000.03 M
Income before tax-10 M-10 M-12 M-1 M-6 M-2 M-4 M-3 M-899000.0-331000.0
Interest income-18000.0-1 M-5 M-10 M
InterestExpenseNonOperating2000.0741000.0999000.0934000.059000.048000.077000.0113000.0128000.0135000.0
LossAndLossAdjustmentExpectedIncurred-73000.0
MarketingExpense2 M2 M3 M
MiscOtherSpecialCharges-23000.0-828000.02 M15 M-1 M1 M2 M207000.01 M-13000.0
Net income from total operations-10 M-10 M-5 M-1 M-6 M-2 M-4 M-3 M-899000.0-331000.0
NetIncomeCommonStockholders-11 M-10 M-5 M-1 M-6 M-2 M-4 M-3 M-899000.0-331000.0
NetIncomeContinuousOperations-10 M-10 M-5 M-1 M-6 M-2 M-4 M-3 M-899000.0-331000.0
NetIncomeDiscontinuousOperations1000000.0
NetNonOperatingInterestIncomeExpense-2000.0-2 M-6 M-11 M-59000.0-48000.0-77000.0-113000.0-128000.0-135000.0
NonRecurringOperationExpense3 M
Normalized income-2 M3 M
Operating income-10 M-8 M-2 M-5 M-5 M-3 M-6 M-3 M-2 M-183000.0
Operating income before depreciation (EBITDA)-9 M-9 M-11 M186000.0-6 M-2 M-4 M-2 M-509000.022000.0
OperatingExpense13 M12 M14 M10 M10 M10 M11 M7 M9 M5 M
Other income net23000.0828000.0-2 M-15 M1 M-1 M-2 M-207000.0-1 M13000.0
Other special charges-26000.0-30000.0
OtherGandA7 M6 M6 M5 M5 M5 M7 M4 M4 M3 M
OtherImpairmentOfCapitalAssets-190000.0-52000.0-92000.0-330000.0
OtherOperatingExpenses-490000.0682000.0682000.0452000.0
OtherunderPreferredStockDividend2 M
PreferredStockDividends2 M
PromotionAndAdvertising245000.0165000.0220000.0
ProvisionForGainLossOnDisposal1000000.0
RentAndLandingFees7 M6 M6 M5 M5 M5 M
Research & development expense4 M4 M5 M3 M3 M2 M1 M988000.0695000.0492000.0
ResearchExpense4 M4 M5 M3 M3 M2 M1 M988000.0695000.0492000.0
Revenue per share-117000.0-129000.091000.091000.081000.0
SalariesAndWages-2 M-2 M-1 M-972000.0-1 M-2 M-2 M-1 M-644000.0
Selling Gen & administrative expense10 M8 M8 M7 M8 M8 M10 M6 M8 M5 M
SellingAndMarketingExpense2 M2 M3 M3 M2 M3 M3 M2 M4 M1 M
SellingExpense2 M3 M3 M2 M3 M3 M2 M1 M
Special income/charges26000.030000.0330000.01 M607000.01.0-3 M250000.0-3 M
Total Income available for interest expense (EBIT)-10 M-10 M-11 M-145000.0-6 M-2 M-4 M-3 M-771000.0-196000.0
Total common shares outstanding744758.01 M2 M4 M6 M8 M8 M8 M8 M8 M
Total net income-10 M-10 M-5 M-1 M-6 M-2 M-4 M-3 M-899000.0-331000.0
Total ordinary shares8 M8 M8 M8 M8 M8 M8 M8 M8 M8 M
Total revenues5 M6 M14 M7 M7 M11 M9 M7 M7 M8 M
TotalExpenses12 M10 M12 M8 M8 M6 M15 M17 M18 M13 M
TotalRevenue5 M6 M7 M7 M7 M11 M9 M7 M7 M8 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University